End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,16,380 COP | 0.00% | +2.01% | +1.26% |
12:39pm | US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug | RE |
24/06 | US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit | RE |
Official Publications
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Shareholders meeting voting results | CO | |
SEC Filing 8K | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 13G | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
SEC Filing 8K | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- News Johnson & Johnson
- Official Publications